Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Johnson and Johnson
Dow
Moodys
Boehringer Ingelheim

Last Updated: December 7, 2021

DrugPatentWatch Database Preview

Litigation for dalfampridine


Email this page to a colleague

« Back to Dashboard

US Court Litigation for dalfampridine

Patent Trial and Appeal Board Cases for dalfampridine

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
8,007,826 Coalition for Affordable Drugs (ADROCA) LLC ⤷  Try it Free 2015-02-27 02-27-2015 Acorda Therapeutics, Inc. Inter partes review ⤷  Try it Free 08-24-2015 Andrew Blight ⤷  Try it Free
8,007,826 Coalition For Affordable Drugs (ADROCA) LLC ⤷  Try it Free 2015-09-02 09-02-2015 Acorda Therapeutics, Inc. Inter partes review ⤷  Try it Free 03-11-2016 Andrew Blight ⤷  Try it Free
8,354,437 Coalition for Affordable Drugs (ADROCA) LLC ⤷  Try it Free 2015-09-03 09-03-2015 Acorda Therapeutics, Inc. Inter partes review ⤷  Try it Free 03-11-2016 Andrew Blight ⤷  Try it Free
8,440,703 Coalition For Affordable Drugs (ADROCA) LLC ⤷  Try it Free 2015-09-02 09-02-2015 Acorda Therapeutics, Inc. Inter partes review ⤷  Try it Free 03-11-2016 Andrew Blight ⤷  Try it Free
8,663,685 Coalition for Affordable Drugs (ADROCA) LLC ⤷  Try it Free 2015-02-10 02-10-2015 Acorda Therapeutics, Inc. Inter partes review ⤷  Try it Free 08-24-2015 Andrew Blight ⤷  Try it Free
8,663,685 Coalition For Affordable Drugs (ADROCA) LLC ⤷  Try it Free 2015-09-03 09-03-2015 Acorda Therapeutics, Inc. Inter partes review ⤷  Try it Free 03-11-2016 Andrew Blight ⤷  Try it Free
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Baxter
Dow
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.